Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. (ANTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANTH · as of Jun 8, 2026
Key Statistics
Explore Anthera Pharmaceuticals, Inc. Data
anth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 66.7%
Competitors & Peers
anth competitorsANTH
CMRA
COTQF
GBIM
NTII
OVITStock Performance
Full HistoryAbout Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's p…
what is anthera pharmaceuticals, inc. · anth stock overview · anthera pharmaceuticals, inc. company profile · who is anthera pharmaceuticals, inc. ceo · anth OTC · anthera pharmaceuticals, inc. headquarters · anthera pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Anthera Pharmaceuticals, Inc. (ANTH) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 1, 2010. As of the latest trading session, ANTH stock price is $0.00, with a market capitalization of $26,179. The stock has returned +900.00% over the past 12 months and +900.00% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Anthera Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2017, Anthera Pharmaceuticals, Inc. reported revenue of — and net income of -$16.9M. For detailed data — including Anthera Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Anthera Pharmaceuticals, Inc. (ANTH) stock price is $0.00. The stock is traded on OTC under the ticker symbol ANTH. The 52-week range is $0.00 – $0.00.